Poster 43
- May 23, 2023
- 1 min read
Bimekizumab Leads to Sustained Flare-Free Status in Moderate-to-Severe Hidradenitis Suppurativa: 3-Year Data from BE HEARD EXT
Steven Daveluy, Haley B. Naik, Ziad Reguiai, Sayaka Yamaguchi, Pablo Fernández-Peñas, Bartosz Lukowski, Christina Crater, Nicola Tilt, Antonio Martorell


